2 results
Approved WMOCompleted
Establishing the pharmacokinetics of intranasally and intramuscularly administered cobalamin in elderly.
Approved WMOWill not start
Primary objectiveTo assess the efficacy of tildrakizumab treatment (as assessed by PASI 75) in moderate-to-severe plaque psoriasis patients who are non-responders to DMF. Secondary objectivesTildrakizumab- To assess the efficacy of tildrakizumab…